Compare
BioRestorative Therapies, Inc. vs Mangoceuticals, Inc. vs Pacific Health Care Organization Inc vs Marpai, Inc.
| Latest fiscal year | BioRestorative Therapies, Inc. BRTX | Mangoceuticals, Inc. MGRX | Pacific Health Care Organization Inc PFHO | Marpai, Inc. MRAI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $359.7K | $456.0K | $6.72M | $18.10M |
| Revenue growth (YoY) | -10.3% | -26.0% | +10.7% | -35.8% |
| Gross margin | 93.4% | 54.9% | n/a | n/a |
| Operating margin | n/m | n/m | 14.9% | -74.9% |
| Net margin | n/m | n/m | 20.7% | -91.5% |
| Net income | -$14.24M | -$20.64M | $1.39M | -$16.56M |
| EPS (Diluted) | -$1.58 | -$2.17 | $0.11 | -$0.95 |
| Operating cash flow | -$10.79M | -$5.85M | $1.16M | -$7.45M |
| Free cash flow | -$10.91M | n/a | $1.14M | n/a |
| Cash & equivalents | $1.51M | $1.49M | $2.17M | $133.0K |
| Total assets | $4.08M | $16.09M | $13.46M | $10.90M |
| Total liabilities | n/a | $890.6K | n/a | $43.47M |
| Shareholders' equity | $356.7K | $15.20M | $13.07M | -$32.56M |
| Return on year-end equity | n/m | -135.8% | 10.6% | n/a |
| Shares outstanding | 8.88M | 15.89M | 12.80M | 24.04M |
Revenue, most recent five fiscal years
| Fiscal year | BioRestorative Therapies, Inc. | Mangoceuticals, Inc. | Pacific Health Care Organization Inc | Marpai, Inc. |
|---|---|---|---|---|
| Latest | $359.7K Ended 2025-12-31 | $456.0K Ended 2025-12-31 | $6.72M Ended 2025-12-31 | $18.10M Ended 2025-12-31 |
| 1 year earlier | $401.0K Ended 2024-12-31 | $615.9K Ended 2024-12-31 | $6.07M Ended 2024-12-31 | $28.17M Ended 2024-12-31 |
| 2 years earlier | $145.8K Ended 2023-12-31 | $731.5K Ended 2023-12-31 | $5.63M Ended 2023-12-31 | $37.16M Ended 2023-12-31 |
| 3 years earlier | $119.8K Ended 2022-12-31 | $8.9K Ended 2022-12-31 | $5.74M Ended 2022-12-31 | n/a |
| 4 years earlier | $46.0K Ended 2021-12-31 | n/a | $5.40M Ended 2021-12-31 | n/a |